New Issue: Orbital Catastrophe Ahead? Read Now

Antibiotics in Blood Can Make Malaria Mosquitoes Mightier

The drugs disrupt mosquitoes' gut bacteria, which appears to make the insects more effective malaria vectors. Christopher Intagliata reports

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


It's well known that antibiotics can disrupt our gut bacteria. But when mosquitoes snack on blood laced with antibiotics, the same can happen to their microbiome. And that depletion of gut bacteria actually increases mosquitoes' susceptibility to the malaria parasite. Meaning they may be more likely to host and then spread the disease-causing protozoan. That's according to a study in the journal Nature Communications. [Mathilde Gendrin et al, Antibiotics in ingested human blood affect the mosquito microbiota and capacity to transmit malaria]

Researchers fed mosquitoes the blood of children infected with the malaria parasite. They added a penicillin-streptomycin antibiotic cocktail to some samples, and a control solution to others. Turns out the mosquitoes that sucked the blood doped with antibiotics were more likely to pick up the parasite. And those mosquitoes appeared to gain some benefit from the antibiotics too—they lived longer and had more offspring than the other mosquitoes in the tests. So these commonly used antibiotics made the insects a more powerful vector for malaria.

Some antibiotics, of course, do inhibit malaria transmission. Doxycycline, for example, is sometimes taken as a malaria prophylactic. 

"Different antibiotics may have different impacts. Which could translate into an opposite effect than what we demonstrated in the paper." Study author George Christophides, of Imperial College London. 

He says this interaction is especially worth considering for patients with malaria as well as tuberculosis or HIV—because treatment of those conditions can involve receiving antibiotics for months. "TB and HIV prevalence in malaria-endemic countries is huge. So if all these people are taking antibiotics, we must know what they do on malaria transmission." Christophides and his colleagues are now investigating those connections—to make sure certain antibiotics don't turn the mosquito into a whole new kind of 'superbug.'

—Christopher Intagliata

[The above text is a transcript of this podcast.]

[Scientific American is part of Nature Publishing Group.]
 

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe